A carregar...
Novel therapies in urothelial carcinoma: a biomarker-driven approach
Urothelial malignancies, including carcinomas of the bladder, ureters, and renal pelvis comprised ∼8% of new cancer cases in the USA in 2016. In the metastatic setting, 15% of patients exhibit long-term survival following cisplatin-based chemotherapy and in patients with recurrent disease, response...
Na minha lista:
| Publicado no: | Ann Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6887951/ https://ncbi.nlm.nih.gov/pubmed/30016395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdy254 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|